Drug Approval | January 14, 2022
Glenmark receives U.S. FDA approval for Ryaltris
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The product will be marketed under store brand labels and is comparable to the brand Zyrtec
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The long-term partnership aims to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative
Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel
Subscribe To Our Newsletter & Stay Updated
